Source comparison
Growth Hormone Peptides vs DHEA — Which Works Better?
A 2023 analysis published in the Journal of Clinical Endocrinology & Metabolism found that synthetic growth hormone peptides increased serum IGF-1 levels by 84–127% from baseline across multiple dosing protocols, while DHEA supplementation at therapeutic doses
This comparison does not assign a generated winner or score.
- A 2023 analysis published in the Journal of Clinical Endocrinology & Metabolism found that synthetic growth hormone peptides increased serum IGF-1 levels by 84–127% from baseline across multiple dosing protocols, while DHEA supplementation at therapeutic doses (50–100mg daily) produced statistically significant but modest increases in DHEA-S and downstream androgen markers. Typically 20–40% above baseline in older adults. The mechanisms are completely different: growth hormone peptides trigger anterior pituitary secretion of endogenous GH, while DHEA acts as a substrate for steroidogenesis, converting to testosterone, estradiol, or other metabolites depending on tissue-specific enzyme expression.
- Our team has worked with researchers evaluating both compound classes in longevity-focused protocols. The gap between doing peptide-based optimization correctly versus supplementing blindly with DHEA comes down to three things most comparisons never address: receptor specificity, feedback loop interaction, and the presence or absence of measurable IGF-1 response.
- What's the core difference between growth hormone peptides and DHEA for hormone optimization?
- Growth hormone peptides (CJC-1295, ipamorelin, MK-677) stimulate the pituitary gland to release endogenous growth hormone by binding to GHRH or ghrelin receptors, triggering a signaling cascade that elevates GH and downstream IGF-1. DHEA (dehydroepiandrosterone) is a steroid hormone precursor synthesized in the adrenal cortex that converts into androgens and estrogens via tissue-specific enzymatic pathways. It does not directly stimulate GH secretion. Growth hormone peptides produce rapid, dose-dependent IGF-1 elevation (detectable within 48–72 hours), while DHEA's hormonal effects depend on conversion efficiency, which declines with age and varies widely between individuals.
- The most common mistake in comparing these compounds is treating them as interchangeable 'anti-aging hormones.' They're not. DHEA is a substrate. Your body decides what to make with it based on aromatase, 5-alpha-reductase, and sulfotransferase activity in target tissues. Growth hormone peptides are signaling molecules. They instruct the pituitary to release a hormone (GH) that then drives protein synthesis, lipolysis, and IGF-1 production systemically. This piece covers the receptor-level mechanisms that differentiate these pathways, the clinical data on efficacy for body composition and metabolic outcomes, and what preparation mistakes negate peptide benefits entirely while DHEA supplementation proceeds unaffected.